STOCK TITAN

Labcorp to Speak at the UBS Global Healthcare Conference

Labcorp (NYSE: LH) announced that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Labcorp (NYSE: LH) announced that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10.

The fireside chat is scheduled for 8:45 a.m. ET. A live audio webcast will be available at ir.labcorp.com, with a replay archived for 180 days following the event.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10 at 8:45 a.m. ET.

Labcorp Logo

A live audio webcast of the fireside chat will be available via the Labcorp Investor Relations website at ir.labcorp.com and archived for replay for 180 days following the event.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-ubs-global-healthcare-conference-302928510.html

SOURCE Labcorp Holdings Inc

Keep reading